Cochrane · systematic review · CD008619
Morita therapy for anxiety disorders in adults
Wu, H, Yu, D, He, Y, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library
Common Mental DisordersAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
14
current version
GRADE rated
7
No studies
7
Included studies
NR
No studies 7 · 50%Ungraded 0 · 0%Very low 7 · 50%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Morita therapy compared with pharmacological therapy for social phobia in adults
Population: people with social phobia
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Global state responders Morita therapy vs pharmacological therapy | RR 1.85 [1.27, 2.69] | 2 studies · 75 participants | Very low Downgraded: risk of bias, imprecision |
Acceptability ‐ drop‐outs for any reason Morita therapy vs pharmacological therapy | no estimate extracted | NR | No studies |
Measures of anxiety overall mean endpoint score of 'Anxiety' and 'Phobic anxiety ' in SCL‐90 (high = poor) Morita therapy vs pharmacological therapy | no estimate extracted | 1 study · 39 participants | Very low Downgraded: risk of bias, imprecision |
Measures of depression overall mean endpoint score of 'Depression' in SCL‐90 (high = poor) Morita therapy vs pharmacological therapy | no estimate extracted | 1 study · 39 participants | Very low Downgraded: risk of bias, imprecision |
Measures of obsession and compulsion endpoint data or change data Morita therapy vs pharmacological therapy | no estimate extracted | NR | No studies |
Quality of life measures endpoint data or change data Morita therapy vs pharmacological therapy | no estimate extracted | NR | No studies |
Measures of functioning endpoint data or change data Morita therapy vs pharmacological therapy | no estimate extracted | NR | No studies |
Morita therapy plus pharmacological therapy compared with pharmacological therapy alone for anxiety disorders
Population: people with anxiety disorders
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Global state responders Morita therapy plus pharmacological therapy vs pharmacological therapy alone | no estimate extracted | NR | No studies |
Acceptability drop‐outs for any reason Morita therapy plus pharmacological therapy vs pharmacological therapy alone | RR 1.76 [0.47, 6.67] | 2 studies · 172 participants | Very low Downgraded: risk of bias, imprecision |
Measures of anxiety overall mean endpoint score of HAMA (high = poor) Morita therapy plus pharmacological therapy vs pharmacological therapy alone | no estimate extracted | 1 study · 103 participants | Very low Downgraded: risk of bias, imprecision |
Measures of depression overall mean endpoint score of HAMD (high = poor) Morita therapy plus pharmacological therapy vs pharmacological therapy alone | no estimate extracted | 1 study · 56 participants | Very low Downgraded: risk of bias, imprecision |
Measures of obsession and compulsion overall mean endpoint score of Y‐BOCS (high = poor) Morita therapy plus pharmacological therapy vs pharmacological therapy alone | no estimate extracted | 2 studies · 159 participants | Very low Downgraded: risk of bias, imprecision |
Quality of life measures ‐ endpoint data or change data Morita therapy plus pharmacological therapy vs pharmacological therapy alone | no estimate extracted | NR | No studies |
Measures of functioning ‐ endpoint data or change data Morita therapy plus pharmacological therapy vs pharmacological therapy alone | no estimate extracted | NR | No studies |